Procter & Gamble Health Limited has informed the Exchange regarding Appointment of Mr Shashank Srowthy as Executive Director of the company w.e.f. October 01, 2025.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has announced the appointment of Mr Shashank Srowthy as Executive Director of the company, effective October 01, 2025. The announcement was made to the exchange as part of standard corporate disclosure requirements regarding changes to the board. No further details such as tenure, compensation, or role specifics were provided in the filing. Shareholders and investors should refer to the company's official filing for additional context on this leadership addition.
This is a routine board-level appointment disclosure and is unlikely to have an immediate material impact on the stock price. It signals continuity in the company's governance structure.